Skip to main content

Advertisement

Log in

Home Monitoring for Age-related Macular Degeneration

  • Retina (J Fortun, Section Editor)
  • Published:
Current Ophthalmology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This article seeks to summarize the history of patient-based monitoring systems for age-related macular degeneration, as well as recent new and emerging technologies in the field of home surveillance.

Recent Findings

New commercially available products, such as ForeseeHome and Paxos, offer improved modalities for home monitoring of macular degeneration, and home optical coherence tomography provides the potential for further improvement in the future.

Summary

While traditional Amsler grid monitoring has provided a useful test for patients to monitor their vision, it has found to have limited specificity and sensitivity as a screening tool for neovascular macular degeneration. Technologies such as ForeseeHome offer a new standard of care with improved accuracy in detection neovascularization early in its disease course, allowing for early intervention to improve patient outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Marmor MF. A brief history of macular grids: from Thomas Reid to Edvard Munch and Marc Amsler. Surv Ophthalmol. 2000;44(4):343–53. https://doi.org/10.1016/S0039-6257(99)00113-7.

    Article  CAS  PubMed  Google Scholar 

  2. Augustin AJ, Offermann I, Lutz J, Schmidt-Erfurth U, Tornambe P. Comparison of the original Amsler grid with the modified Amsler grid: result for patients with age-related macular degeneration. Retina. 2005;25(4):443–5. https://doi.org/10.1097/00006982-200506000-00008.

    Article  PubMed  Google Scholar 

  3. Schlaegel TF Jr, Cofield DD, Clark G, et al. Photocoagulation and other therapy for histoplasmic choroiditis. Trans Am Acad Ophthalmol Otolaryngol. 1968;72(3):355–63.

    PubMed  Google Scholar 

  4. The Macular Photocoagulation Study Group. Early detection of extrafoveal neovascular membranes by daily central field evaluation. Ophthalmology. 1985;92:603–9.

    Article  Google Scholar 

  5. Schuchard RA. Validity and interpretation of Amsler grid reports. Arch Ophthalmol. 1993;111(6):776–80. https://doi.org/10.1001/archopht.1993.01090060064024.

    Article  CAS  PubMed  Google Scholar 

  6. Zaidi FH, Cheong-Leen R, Gair EJ, Weir R, Sharkawi E, Lee N, et al. The Amsler chart is of doubtful value in retinal screening for early laser therapy of subretinal membranes. The West London Survey Eye. 2004;18(5):503–8. https://doi.org/10.1038/sj.eye.6700708.

    CAS  PubMed  Google Scholar 

  7. Trevino R. Recent progress in macular function self-assessment. Ophthalmic Physiol Opt. 2008;28(3):183–92. https://doi.org/10.1111/j.1475-1313.2008.00561.x.

    Article  PubMed  Google Scholar 

  8. Loewenstein A, Malach R, Goldstein M, Leibovitch I, Barak A, Baruch E, et al. Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration. Ophthalmology. 2003;110(5):966–70. https://doi.org/10.1016/S0161-6420(03)00074-5.

    Article  PubMed  Google Scholar 

  9. Elman MJ. Home monitoring of dry AMD patients. Retina Today. 2016;11:76–8.

    Google Scholar 

  10. Trevino R, Kynn MG. Macular function surveillance revisited. Optometry. 2008;79(7):397–403. https://doi.org/10.1016/j.optm.2007.09.017.

    Article  PubMed  Google Scholar 

  11. The Preferential Hyperacuity Perimeter Research Group. Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration. Retina. 2005;25(3):296–303. https://doi.org/10.1097/00006982-200504000-00008.

    Article  Google Scholar 

  12. The Preferential Hyperacuity Perimetry Research Group. Preferential hyperacuity perimeter for detecting choroidal neovascularization study. Ophthalmology. 2005a;112:1758–65.

    Article  Google Scholar 

  13. Kampmeier J, Zorn MM, Lang GK, Botros YT, Lang GE. Vergleich des Preferential-Hyperacuity-Perimeter (PHP)-tests mit dem Amsler-netz-test bei der diagnose verschiedener stadien der altersbezogenen makuladegeneration. Klin Monatsbl Augenheilkd. 2006;223(9):752–6. https://doi.org/10.1055/s-2006-926880.

    Article  CAS  PubMed  Google Scholar 

  14. Loewenstein A, Ferencz JR, Lang Y, Yeshurun I, Pollack A, Siegal R, et al. Toward earlier detection of choroidal neovascularization secondary to age-related macular degeneration: multicenter evaluation of a preferential hyperacuity perimeter designed as a home device. Retina. 2010;30(7):1058–64. https://doi.org/10.1097/IAE.0b013e3181d1a75e.

    Article  PubMed  Google Scholar 

  15. Chew EY, Clemons TE, Bressler SB, AREDS2-Home Study Research Group, et al. Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the eye (HOME) study. Ophthalmology. 2014;121(2):535–44. https://doi.org/10.1016/j.ophtha.2013.10.027.

    Article  PubMed  Google Scholar 

  16. Kirkner RM. An app to monitor patients at home. Retina Specialist. 2016;5:44.

    Google Scholar 

  17. Yu SY, Yang JH, Kim Y, et al. Reliability of smartphone-based electronic visual acuity testing: (applications in remote monitoring and clinical research of macular pathology). Invest Ophthalmol Vis Sci. 2014;55(13):5598.

    Google Scholar 

  18. Blumenkranz MS. The power of more data in managing AMD. Retin Physician. 2016;13:58–70.

    Google Scholar 

  19. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 - . Identifier NCT02871817, A comparison of the Paxos Mobile App to Standard Vision Assessment Tools (CLEAR); 2017 [cited 2017 Sept 30]; Available from: https://clinicaltrials.gov/ct2/show/NCT02871817

  20. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 - . Identifier NCT01863199, Impact of home monitoring to decrease the treatment burden for neovascular age-related macular degeneration (AMD) (Liberty); 2015 [cited 2017 Sept 30]; Available from: https://clinicaltrials.gov/ct2/show/NCT01863199

  21. Harrison L. Smartphones hold implications for retinal screening, beyond. Modern Retina [Internet]. 2016 Feb [cited 2017 Sept 30]; Available from: http://modernretina.modernmedicine.com/modern-retina/news/smartphones-hold-implications-retinal-screening-beyond

  22. Toy BC, Myung DJ, He L, Pan CK, Chang RT, Polkinhorne A, et al. Smartphone-based dilated fundus photography and near visual acuity testing as inexpensive screening tools to detect referral warranted diabetic eye disease. Retina. 2016;36(5):1000–8. https://doi.org/10.1097/IAE.0000000000000955.

    Article  PubMed  Google Scholar 

  23. Mallipatna A, Vinekar A, Jayadev C, Dabir S, Sivakumar M, Krishnan N, et al. The use of handheld spectral domain optical coherence tomography in pediatric ophthalmology practice: our experience of 975 infants and children. Indian J Ophthalmol. 2015;63(7):586–93. https://doi.org/10.4103/0301-4738.167108.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Maldonado RS, Izatt JA, Sarin N, Wallace DK, Freedman S, Cotten CM, et al. Optimizing hand-held spectral domain optical coherence tomography imaging for neonates, infants, and children. Invest Ophthalmol Vis Sci. 2010;51(5):2678–85. https://doi.org/10.1167/iovs.09-4403.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Subhash HM, Hogan JN, Leahy MJ. Multiple-reference optical coherence tomography for smartphone applications. SPIE. 2015; https://doi.org/10.1117/2.1201503.005807.

  26. Notal Vision welcomes Roni Amiel as Chief Information Officer [Internet]. 2017 [cited 2017 Sept 30]; Available from: http://www.prnewswire.com/news-releases/notal-vision-welcomes-roni-amiel-as-chief-information-officer-300497437.html

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jorge A. Fortun.

Ethics declarations

Conflict of Interest

Kevin Miller and Jorge Fortun declare no conflict of interest.

Jorge Fortun is a consultant for Notal Vision

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Retina

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miller, K.P., Fortun, J.A. Home Monitoring for Age-related Macular Degeneration. Curr Ophthalmol Rep 6, 53–57 (2018). https://doi.org/10.1007/s40135-018-0163-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40135-018-0163-6

Keywords

Navigation